Towards Healthcare
Gene Prediction Tools Market Booms at 18.72% CAGR by 2034

Gene Prediction Tools Market Segment Analysis and Strategic Insights

Projections indicate that, the global gene prediction tools market will increase from USD 200 million in 2024 to USD 1113.98 million by 2034, experiencing a CAGR of 18.72% over the next 10 years. Currently, the respective market is driven by the accelerating demand for personalized treatments in different conditions and the reduction in expenditure on sequencing technologies. Furthermore, North America dominated the market due to the presence of a robust research infrastructure, funding facilities, which allow the development of personalized medicine in the growing chronic disease cases.

Content

  • Insight Code: 5775
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The market was valued at USD 200 million in 2024, is estimated at USD 237.44 million in 2025, and is projected to reach USD 1113.98 million by 2034, growing at a CAGR of 18.72%.

While North America dominates (42% share in 2024) due to strong R&D ecosystems and chronic disease prevalenc.

AI and ML significantly enhance gene prediction accuracy, reduce analysis time, and support handling of complex genomic datasets.

Key players include Thermo Fisher Scientific, Illumina, Qiagen, Softberry, DNASTAR, Genscript, BGI Genomics, and MedGenome.

High computational and cloud infrastructure costs, data complexity, and ethical issues surrounding genetic data privacy and manipulation are critical restraints.

Increasing regulatory scrutiny around data privacy especially for genetic data, impacts how gene prediction tools are developed and deployed
Any Questions